Clinical Trials Directory

Trials / Conditions / Advanced Pancreatic Ductal Adenocarcinoma

Advanced Pancreatic Ductal Adenocarcinoma

10 registered clinical trials studyying Advanced Pancreatic Ductal Adenocarcinoma — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic
NCT07348107
Daniel BreadnerPhase 1
RecruitingNano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer
NCT07408505
Shandong Cancer Hospital and InstituteN/A
WithdrawnFL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma
NCT06206876
Roswell Park Cancer InstitutePhase 1
RecruitingEvaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
NCT07021066
SystImmune Inc.Phase 1
RecruitingIcaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinom
NCT06825546
Sir Run Run Shaw HospitalPhase 2
RecruitingA First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advan
NCT06585488
BeiGenePhase 1
Active Not RecruitingAGEN1423 and Botensilimab w/ or w/o Chemo in PDAC
NCT05632328
Bruno BockornyPhase 2
UnknownKN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.
NCT05149326
Jiangsu Alphamab Biopharmaceuticals Co., LtdPhase 3
RecruitingLenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancre
NCT04887805
City of Hope Medical CenterPhase 2
Active Not RecruitingStudy Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
NCT02921022
Memorial Sloan Kettering Cancer CenterN/A